NDC 50458-585 – Concerta

Methylphenidate Hydrochloride 18 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug DEA schedule CII

Product NDC50458-585

Product details

Brand name
Concerta
Generic name
Methylphenidate hydrochloride
Labeler
Janssen Pharmaceuticals, Inc.
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
NDA · NDA021121
Marketed since
August 1, 2000
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Concerta →

Package NDC codes (1)

Package NDCDescriptionSince
50458-585-01100 TABLET, EXTENDED RELEASE in 1 BOTTLE (50458-585-01)Aug 1, 2000

Other Concerta products